scispace - formally typeset
B

Brett K. Beaulieu-Jones

Researcher at Harvard University

Publications -  59
Citations -  3393

Brett K. Beaulieu-Jones is an academic researcher from Harvard University. The author has contributed to research in topics: Medicine & Deep learning. The author has an hindex of 16, co-authored 47 publications receiving 2147 citations. Previous affiliations of Brett K. Beaulieu-Jones include Brigham and Women's Hospital & Beth Israel Deaconess Medical Center.

Papers
More filters
Proceedings ArticleDOI

Missing data imputation in the electronic health record using deeply learned autoencoders.

TL;DR: It is shown that despite clinical heterogeneity, ALS disease progression appears homogenous with time from onset being the most important predictor.
Journal ArticleDOI

Reproducibility of computational workflows is automated using continuous analysis

TL;DR: The development of continuous analysis is reported, a workflow that enables reproducible computational analyses and allows reviewers, editors or readers to verify reproducibility without manually downloading and rerunning code and can provide an audit trail for analyses of data that cannot be shared.
Journal ArticleDOI

International electronic health record-derived COVID-19 clinical course profiles: the 4CE consortium

Gabriel A. Brat, +88 more
TL;DR: An international consortium of 96 hospitals across five countries formed an international consortium (4CE) to capture the trajectory of COVID-19 disease in patients and their response to interventions and established a framework to capture this trajectory.
Journal ArticleDOI

Characterizing and Managing Missing Structured Data in Electronic Health Records: Data Analysis.

TL;DR: This study demonstrates how the mechanism of missingness can be assessed, evaluate the performance of a variety of imputation methods, and describes some of the most frequent problems that can be encountered in dealing with missing EHR data.
Journal ArticleDOI

Examining the Use of Real-World Evidence in the Regulatory Process

TL;DR: The advantages and limitations of Rwe are summarized, the key opportunities for RWE are identified, and the way forward to maximize the potential of RWE for regulatory purposes is pointed the wayforward.